Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 2 of 2 entries
View as:
Phase: N/A
Priority: Normal
Start: 10/31/05
End: 12/31/08
Due: 12/31/09
Phase: N/A
Priority: Normal
Start: 03/31/08
End: 10/31/10
Due: 10/31/11
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| Serp-1 for the Treatment of Acute Coronary Syndrome | NCT00243308 | Viron Therapeutics Inc | user2@example.com | None | 2005-10-31 | 2008-12-31 | 2009-12-31 | - | - | 2025-07-14 |
| Treatment of Elderly Patients With Acute Myeloid Leukemia (AML) and High Risk Myelodysplastic (MD) Syndrome With Laromustine and Infusional Cytarabine | NCT00655395 | Viron Therapeutics Inc | user2@example.com | None | 2008-03-31 | 2010-10-31 | 2011-10-31 | - | - | 2025-07-14 |